Data for ST003281   

(Analysis AN005376): Average values per metabolite and experimental factor (Units:Rel Abundance)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12
1-Heneicosanoyl-glycero-3-phosphoserine
617.87 8944.90 249.33 4294.80 3278.57
DGGA 16:0_18:1
4993.10 184.43 14806.33 240.63 4807.17
DGGA 16:0_18:2
12527.67 273.50 26975.50 376.70 10494.60
PA(20:5-OH(5)/a-25:0)
313.07 1465.57 415.80 3291.43 949.53
PC(18:1/TXB2)
821.23 5271.70 342.97 8660.63 5123.33
PC(PGE1/P-16:0)
114.33 427.03 65.20 2051.37 715.77
PE(16:0/18:1)
908.67 1462.80 747.67 4723.23 1696.73
PE 16:0_18:2
1262.37 1637.37 615.63 5279.87 2001.60
PE 18:1_18:1
890.67 7592.70 480.83 16604.87 5847.83
PE 18:1_18:2
2221.70 17423.20 937.40 38832.13 15508.70
PE 18:2_18:2
1655.10 8539.10 700.47 24236.90 8849.13
PE(20:0/18:1-2OH)
477.90 2019.90 413.10 4464.17 1751.90
PE(20:0/PGF1alpha)
4387.93 37714.60 1397.53 86851.57 31399.07
PE(20:1/18:1-2OH)
1378.07 6557.33 1015.67 16892.17 5956.43
PE(20:1/PGF1alpha)
4596.50 37984.13 1344.27 90877.63 37275.10
PE(TXB2/22:1)
777.73 1295.60 1161.93 2764.57 1470.03
PI 16:0_18:1
2571.03 4230.03 2191.17 9971.20 4199.40
PI 16:0_18:2
3210.67 4744.63 2591.53 12151.37 5103.60
PS(18:0/18:1)
193.47 1377.53 106.07 2724.47 1045.23
PS(18:1/18:2)
355.57 1499.53 153.73 3597.03 1572.77
PS(18:2/18:0)
443.83 2971.63 219.47 5633.10 2681.17
PS(22:0/18:1-2OH)
297.70 2253.60 192.60 4541.97 1500.07
PS(22:1/18:1-2OH)
837.10 5261.77 335.90 8767.63 4363.67
PS(24:1/15:0)
1233.80 13476.50 703.83 29616.60 8989.23
SM(d18:2/TXB2)
2588.83 271.23 4796.33 552.50 2222.47

Factors:

F1Genotype:H99 | Treatment:0
F2Genotype:H99 | Treatment:250
F3Genotype:H99 | Treatment:H99-iron-20Pi-24h
F4Genotype:H99 | Treatment:H99-iron-20Pi-6h
F5Genotype:H99 | Treatment:H99-iron-24h
F6Genotype:H99 | Treatment:H99-iron-6h
F7Genotype:H99 | Treatment:H99-no iron-20Pi-6h
F8Genotype:H99 | Treatment:H99-no iron-6h
F9Genotype:H99 | Treatment:QC
F10Genotype:Pho | Treatment:0
F11Genotype:Pho | Treatment:250
F12Genotype:QC | Treatment:QC
  logo